Capture

Investing in Influence: Investors, Portfolio Firms, and Political Giving

A new paper examines the relationship between the rising concentration in institutional investors' ownership of publicly traded U.S. firms and portfolio companies' political giving....

Industrial Policy Is a Seductive Mirage

Industrial policy was once so out of fashion that it was jokingly called “the policy that shall not be named.” Now it’s back in...

Survey Highlights Backlash to Increasingly Political Corporate America

A recent poll shows that 71% of Americans view large companies negatively. The change has been driven by Republicans who dislike the rise of...

Event Notes: Academic Bias Under the Microscope

That scholarship often reflects conscious and unconscious biases has long been an open secret in academia. On April 22, Professors Christian Leuz, Anat Admati,...

Corporations Are Not “We the People”

The Citizens United ruling contradicts the Founders, decades of Supreme Court precedent and the will of the American people. There is nothing in the text...

What Citizens United Did Not Predict and Why It’s Time To Reconsider

Citizens United v. FEC stands in the public eye as the U.S. Supreme Court case that flooded U.S. elections with “dark money” and SuperPACs....

Companies’ Diversity Commitments Conflict with Political Donations

Many US businesses that promote their workplaces as supportive of traditionally marginalized groups have created diversity, equity and inclusion (DEI) programs for their employees....

“Uber Has Higher Prices and Worse Service Than the Taxi Industry Had Ten Years Ago”

Following the Uber Files leaks, transportation expert Hubert Horan explains why Uber is “hopelessly uneconomic” and how its engagement with policymakers and academics aided...

Relationships With Academics at the Center of the Uber Files Revelations 

The Guardian’s exposé on Uber’s strategy of engaging with top academic researchers to produce corporate-friendly research calls to mind concerns regarding academic lobbying and...

Healthcare Companies Spent More on Lobbying Than Any Other Industry Last Year

Threatened by regulated price caps from congress, the pharmaceutical industry spent nearly $390 million on lobbying in 2021 according to new data from OpenSecrets. Healthcare...

Latest news